Covid-19 convalescent plasma therapy: Analyzing the factors that led to its failure in India.

Bansal, Naveen; Raturi, Manish; Bansal, Yashik

Bansal, Naveen; Raturi, Manish; Bansal, Yashik.

Bansal N; Department of Transfusion Medicine, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India.
Raturi M; Department of Immunohematology and Blood Transfusion, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Jolly Grant, 248016 Dehradun, Uttarakhand, India. Electronic address: manishraturi@srhu.edu.in.
Bansal Y; Department of Microbiology and Immunology, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India.

Transfus Clin Biol ; 28(3): 296-298, 2021 08.

Article in English | MEDLINE | ID: covidwho-1253698

Subject(s)

COVID-19/therapy; Pandemics; SARS-CoV-2; COVID-19/complications; COVID-19/epidemiology; COVID-19/immunology; Clinical Trials as Topic/statistics & numerical data; Cytokine Release Syndrome/etiology; Cytokine Release Syndrome/mortality; Disease Management; Humans; Immune Evasion/genetics; Immunization, Passive/statistics & numerical data; India/epidemiology; Multicenter Studies as Topic/statistics & numerical data; Mutation; Patient Selection; SARS-CoV-2/genetics; SARS-CoV-2/immunology; Selection, Genetic; Tertiary Care Centers/statistics & numerical data; Treatment Failure; COVID-19 Serotherapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: Transfus Clin Biol Journal subject: Hematology Year: 2021 Document Type: Article Affiliation country: J.tracli.2021.05.009

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google